Taiko Pharmaceutical Co.,Ltd. (4574.T)

JPY 322.0

(0.0%)

Annual Income Statements

(In JPY)
Breakdown 2022 2021 2020 2020 2019 2018
Revenue 5.04 Billion 10.72 Billion 17.68 Billion 14.93 Billion 10.37 Billion 9.43 Billion
Cost of Revenue 3.96 Billion 7.97 Billion 5.26 Billion 4.35 Billion 3.21 Billion 2.88 Billion
Gross Profit 1.07 Billion 2.74 Billion 12.42 Billion 10.57 Billion 7.16 Billion 6.55 Billion
Operating Expenses 4.15 Billion 7.69 Billion 6.76 Billion 6.75 Billion 5.13 Billion 4.69 Billion
Selling, General and Administrative Expenses - - - - 5.13 Billion 4.69 Billion
Research and Development Expenses - - - - 410 Million -
Other Expenses 4.15 Billion 7.69 Billion 6.76 Billion -282.12 Million -188.13 Million -249.06 Million
Cost and Expenses 8.11 Billion 15.66 Billion 12.03 Billion 11.11 Billion 8.34 Billion 7.58 Billion
Operating Income -3.07 Billion -4.94 Billion 5.65 Billion 3.82 Billion 2.02 Billion 1.85 Billion
Interest Expense 10 Million 6 Million 282 Thousand 394 Thousand - 319.46 Million
Income Tax Expense 25 Million 706 Million 1.52 Billion 1.05 Billion 570.49 Million 457.78 Million
Earnings before Tax -4.86 Billion -8.88 Billion 5.37 Billion 3.5 Billion 1.98 Billion 1.55 Billion
Net Income -4.89 Billion -9.59 Billion 3.85 Billion 2.45 Billion 1.41 Billion 1.09 Billion
Earnings Per Share Basic -112.24 -220.48 89.18 57.57 33.00 25.80
Earnings Per Share Diluted -112.24 -220.48 88.82 57.34 32.96 25.69
Weighted Average Shares Outstanding 43.6 Million 43.5 Million 43.18 Million 42.61 Million 42.89 Million 42.44 Million
Weighted Average Shares Outstanding (Diluted) 43.6 Million 43.5 Million 43.36 Million 42.78 Million 42.94 Million 42.62 Million
Gross Margin 0.21 0.26 0.70 0.71 0.69 0.69
EBIT Margin -0.74 -0.52 0.33 0.27 0.23 0.25
Profit Margin -0.97 -0.89 0.22 0.16 0.14 0.12
EBITDA -3.75 Billion -5.56 Billion 5.92 Billion 4.06 Billion 2.38 Billion 2.32 Billion
Earnings Before Tax Margin -0.61 -0.46 0.32 0.26 0.20 0.20

Income Statement Charts